@article{0dcdc968edc24c93ab0a3a1217da17ef,
title = "Aerobic fitness and adherence to guideline-recommended minimum physical activity among ambulatory patients with type 2 diabetes mellitus",
abstract = "OBJECTIVE Lifestyle intervention remains the cornerstone of management of type 2 diabetes mellitus (T2DM). However, adherence to physical activity (PA) recommendations and the impact of that adherence on cardiorespiratory fitness in this population have been poorly described. We sought to investigate adherence to PA recommendations and its association with cardiorespiratory fitness in a population of patients with T2DM. RESEARCH DESIGN AND METHODS A cross-sectional analysis of baseline data from a randomized clinical trial (NCT00424762) was performed. A total of 150 individuals with medically treated T2DM and atherosclerotic cardiovascular disease (ASCVD) or risk factors for ASCVD were recruited from outpatient clinics at a single academic medical center. All individuals underwent a graded maximal exercise treadmill test to exhaustion with breath-by-breath gas exchange analysis to determine VO2peak. PA was estimated using a structured 7-Day Physical Activity Recall interview. RESULTS Participants had a mean6SD age of 54.969.0 years; 41% were women, 40% were black, and 21% were Hispanic. The mean HbA1c was 7.761.8% and the mean BMI, 34.5 6 7.2 kg/m2. A total of 72% had hypertension, 73% had hyperlipidemia, and 35% had prevalent ASCVD. The mean6SD reported daily PA was 34.364 kcal/kg, only 7% above a sedentary state; 47% of the cohort failed to achieve the minimum recommended PA. Mean 6 SD VO2peak was 27.4 6 6.5 mL/kg fat-free mass/min (18.8 6 5.0 mL/kg/min). CONCLUSIONS On average, patients with T2DM who have or are at risk for ASCVD report low levels of PA and have low measured cardiopulmonary fitness. This underscores the importance of continued efforts to close this therapeutic gap.",
author = "Jarvie, {Jennifer L.} and Ambarish Pandey and Ayers, {Colby R.} and McGavock, {Jonathan M.} and Martin S{\'e}n{\'e}chal and Berry, {Jarett D.} and Patel, {Kershaw V.} and McGuire, {Darren K.}",
note = "Funding Information: Funding. This work was supported by research grants from the Donald W. Reynolds Foundation and the U.S. Public Health Service General Clinical Research Center (grant no. M01-RR00633) at the National Institutes of Health/National Center Research ResourcesdClinical Research. C.R.A. is supported in part by the National Heart, Lung, and Blood Institute (grant no. NIH-NHLBI 1 K23 HL092229-01-A1). Duality of Interest. This work was supported by a research grant from GlaxoSmithKline. D.K.M. has received personal fees for trial leadership from GlaxoSmithKline, Janssen, Lexicon, Astra-Zeneca, Sanofi Aventis, Boehringer Ingelheim, Merck & Co., Pfizer, Novo Nordisk, Eisai Inc., Esperion, and Lilly USA and has received personal consultancy fees from AstraZeneca, Lilly USA, Boehringer Ingelheim, Merck & Co., Novo Nordisk, Metavant Sciences, Applied Therapeutics, and Sanofi Aventis. No other potential conflicts of interest relevant to this article were reported. Author Contributions. J.L.J. and D.K.M. wrote the manuscript, researched the data, and participated in the analyses. A.P. reviewed and edited the manuscript and contributed to the discussion. C.R.A. performed the analyses and edited the manuscript. J.M.M. and M.S. contributed to the discussion and edited the manuscript. J.D.B. and K.V.P. reviewed and edited the manuscript. J.L.J. and D.K.M. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Prior Presentation. Preliminary results were presented at the American Heart Association Quality of Care and Outcomes Research Scientific Sessions, Atlanta, GA, 9–11 May, 2012. Publisher Copyright: {\textcopyright} 2019 by the American Diabetes Association.",
year = "2019",
doi = "10.2337/dc18-2634",
language = "English (US)",
volume = "42",
pages = "1333--1339",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "7",
}